Levels, a metabolic health platform, closed a $38M Series A round, valuing the company at $300M.
Of note, the funding round saw participation exclusively from individual operators—including a crowdfunding campaign—with no institutional investors involved.
Putting the new capital to work, Levels will pursue full consumer availability and international expansion.
The Unseen Epidemic
We’re in the midst of a metabolic crisis.
- Over 128M Americans have prediabetes or diabetes.
- Per the CDC, of the 88M with prediabetes, 90% don’t know they have it.
- 90% of $4T annual healthcare costs in the US are tied to largely preventable chronic conditions — several linked to metabolic dysfunction.
The problem is that most people, even the fittest among us, don’t understand what factors go into good metabolic health.
Levels, creators of software that works with continuous glucose monitors, hopes to provide both the data and context to help improve users’ health. Levels co-founder and chief medical officer Dr. Casey Means says it’s about making lifestyle changes easier:
“Understanding how our choices affect key health biomarkers in real time—and more broadly understanding our own metabolic health—is foundational for optimal health and longevity.”
Recently, Levels remodeled its pricing model to emulate retailer Costco’s value-delivering operation. In its blog post, the brand explained it wants to add more valuable services for its members without thinking about margins.
“[The model] makes it so that we have no incentive to sell more stuff, nor are we incentivized to sell less stuff.”
Wasting no time, earlier this month, Levels launched members-only services for at-home blood testing and access to nutritionists.
New funding secured, Levels will extend beyond its 25K-member beta phase to reach full consumer ability domestically before launching overseas later this year.